Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ELVN
ELVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELVN News
Enliven Therapeutics Closes $460 Million Upsized Public Offering
4d ago
Newsfilter
Enliven Therapeutics Closes $460 Million Upsized Public Offering
4d ago
PRnewswire
Biotech Company Movements Analysis
5d ago
NASDAQ.COM
Enliven Therapeutics Announces Key Trial Alignment and Public Offering
Jun 12 2026
stocktwits
Enliven Therapeutics Upsizes Public Offering to $400 Million
Jun 12 2026
seekingalpha
Enliven Therapeutics Completes Upsized Public Offering
Jun 12 2026
PRnewswire
Enliven Therapeutics Prices Upsized Public Offering
Jun 12 2026
Newsfilter
Enliven Therapeutics Launches $250 Million Public Offering
Jun 11 2026
seekingalpha
Enliven Therapeutics Reports Significant Phase 1 Trial Results for ELVN-001
Jun 11 2026
seekingalpha
Enliven Therapeutics Reports Positive Data for ELVN-001 in CML Trial
Jun 11 2026
PRnewswire
Enliven Therapeutics Reports Positive Data for ELVN-001 in CML Trial
Jun 11 2026
Newsfilter
Enliven to Host Webcast Conference Call on June 11
Jun 03 2026
PRnewswire
Analysis of Executive Stock Transaction at Enliven Therapeutics
Jun 01 2026
Fool
Chief Medical Officer Sells Shares, Reduces Holdings
Jun 01 2026
NASDAQ.COM
Surge in Options Trading Volume for Apple and Coinbase
May 29 2026
NASDAQ.COM
Avidity Partners Increases Stake in Enliven Therapeutics
May 13 2026
Fool
Show More News
